The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
14 | 6 | 55 | 25 |
Growth
|
95 | 99 | 71 | 29 |
Safety
|
16 | 8 | 98 | 87 |
Sentiment
|
97 | 80 | 57 | 47 |
|
66 | 47 | 94 | 21 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
81 | 64 | 67 | 42 |
Opinions Change
|
100 | 28 | 50 | 50 |
Pro Holdings
|
n/a | 82 | 39 | 83 |
Market Pulse
|
82 | 75 | 49 | 26 |
Sentiment
|
97 | 80 | 57 | 47 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
14 | 6 | 55 | 25 |
Growth
|
95 | 99 | 71 | 29 |
|
16 | 8 | 98 | 87 |
Combined
|
28 | 19 | 94 | 56 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
60 | 60 | 60 | 10 |
Price vs. Earnings (P/E)
|
20 | 39 | 59 | 17 |
Price vs. Book (P/B)
|
10 | 4 | 60 | 55 |
Dividend Yield
|
1 | 1 | 1 | 1 |
Value
|
14 | 6 | 55 | 25 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
65 | 91 | 88 | 70 |
Profit Growth
|
69 | 60 | 61 | 28 |
Capital Growth
|
71 | 88 | 58 | 70 |
Stock Returns
|
99 | 95 | 21 | 9 |
Growth
|
95 | 99 | 71 | 29 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
27 | 30 | 100 | 100 |
Refinancing
|
37 | 23 | 75 | 49 |
Liquidity
|
25 | 28 | 26 | n/a |
|
16 | 8 | 98 | 87 |
Discover high‑ranked alternatives to Adaptive Biotechnologies and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.